Earlier this year the first compulsory license, regarding the anti-cancer drug Sorafenib, was granted in India. (See previous blog
Danish case law regarding patents shows that in a vast majority of cases, the Danish Board of Appeal (BoA)
When reading a novel the other day, I came across a statement by a consulting detective. “What one man
I recently wrote about a pending court case regarding an imported counterfeit Rolex watch. The importer, a private person,
Almost a year ago I wrote on the Awapatent IP Blog about the efforts of the EPO and USPTO to
Recently, the International Trademark Association INTA held the first design conference. The number of attendees was 215 and more
My trainee colleagues and I are now in the final stage of our first 5-week theory period. So many
Recently representatives of Awapatent participated in the China Intellectual Property Focus 2012 conference in Shanghai. Our participation is a
The first theory period of the trainee programme is coming to an end. It has been intensive weeks filled
The “trainee tour” has moved on to Gothenburg and we have now spent almost three weeks in the world